Susan Morse
Most people with a health plan can go online or to a pharmacy to purchase an at-home COVID-19 test at no cost.
Hospital leaders on Tuesday will discuss the ongoing toll of COVID-19 on hospitals as the pandemic enters its third year.
Forty-five organizations are getting the American Rescue Plan funds over three years.
Yesterday, 1,900 Americans died from COVID-19, says HHS Secretary Xavier Becerra, in announcing $103 million for healthcare workforce.
Hospitalizations, drug and device shortages, and employee illness and burnout may continue through 2022, AHA says.
This applies in the 24 states where the vaccine mandate was reinstated by last week's Supreme Court's decision.
The Justices upheld mandates for healthcare workers but say OSHA standards overstepped federal power.
Arguments center on Aduhelm's price, its questionable clinical benefit and why the agency is going against FDA approval of the drug.
Currently, Aduhelm, made by Biogen, is the only monoclonal antibody approved by the FDA for the treatment of Alzheimer's disease.
Premiums covered the $56,000 yearly cost of the Alzheimer's drug Aduhelm, but that price has been slashed by 50%.